Skip to content
Welcome, thoughtbot's Giant Robots listeners!Start here
UK Startups and Innovation
22OCT

Midlands fund writes its first cheques

3 min read
16:30UTC

Eight Midlands universities deployed their first £30m together through Midlands Mindforge, backing an antenna firm, an eye-drug platform and a river-water sensor.

← Back to Stryker agrees option to buy CMR SurgicalJump to analysis ↓
TechnologyDeveloping
Key takeaway

Eight Midlands universities pooled £30m to fund their own spinouts, loosening the Golden Triangle's grip on early capital.

Midlands Mindforge deployed its first investments on 10 June, with £30m unlocked and announced by Lord Patrick Vallance at the UK Global R&D and Science Investment Summit⁠1. Eight universities back it together for the first time: Aston, Birmingham, Cranfield, Keele, Leicester, Loughborough, Nottingham and Warwick, alongside both regional Combined Authorities, UK Research and Innovation (UKRI), the Department for Science, Innovation and Technology (DSIT) and the Rigby Group.

The first three companies, names undisclosed, work on antenna technology, an ocular drug-delivery platform and a river-water sensor⁠2. A multi-university fund matters because spinout capital in Britain has clustered for years around three institutions; pooling eight Midlands universities gives the region a single cheque-writing vehicle where founders previously had none.

The £30m is small against the Golden Triangle's billions, yet it is the first Midlands spinout fund to reach deployment. It echoes the £500m innovation pot DSIT handed to seven city-region mayors at the start of the month and the Lansdowne university-IP fund the British Business Bank anchored in May. The Golden Triangle still raises most of the money; the difference now is that the cheques are starting to come from somewhere else.

Deep Analysis

In plain English

UK universities generate a lot of scientific research. Turning that research into companies, a process called spinning out, requires specialist investors who understand both the technology and the legal complexity of university IP (intellectual property) ownership. London universities like UCL and Imperial do this well. Midlands universities historically did not, because no single Midlands university had enough spinout deal flow to justify its own venture fund. Midlands Mindforge solves that by pooling eight universities into one fund. On 10 June 2026, the fund made its first three investments. The companies involved work on antenna technology, an eye-drop drug delivery system and a river pollution sensor. Lord Vallance, the UK Science Minister, announced the investments on 10 June at the UK Global R&D and Science Investment Summit. UKRI, the government's main research funding body, put in public capital alongside the private Rigby Group, a UK investment firm.

Deep Analysis
Root Causes

The three conditions behind Midlands Mindforge arriving in June 2026, rather than five years earlier, are each traceable to a specific policy constraint that was cleared during 2025-26.

First, DSIT's Local Innovation Partnerships Fund (LIPF) devolution, announced 1 June 2026, gave city-region mayors direct control over UKRI-backed capital allocation. Before that change, Midlands universities had to submit UKRI grant applications individually, which produced the Nesta-documented grant-count collapse: fewer companies receiving larger individual awards, with no portfolio logic.

Second, the Rigby Group's private co-investment resolved the evergreen-fund problem that stalled every predecessor. The universities' endowments cannot provide patient capital beyond the typical 10-year fund life. Rigby's backing extends the capital runway without requiring universities to anchor a second fund from their own balance sheets.

Third, the three companies' sectors, antenna technology, ocular drug delivery and river-water sensing, reflect a deliberate avoidance of AI software, where Midlands universities lack the talent density to compete with the Golden Triangle. All three are hardware-based, regulated-market products where Midlands engineering faculties have genuine comparative advantage, a portfolio construction signal that distinguishes Mindforge from prior regional funds that replicated London's AI-software focus.

What could happen next?
  • Opportunity

    The hardware focus of the first three investments (antenna, drug delivery, water sensor) positions Midlands Mindforge in regulated-market sectors where UK universities have comparative advantage over US and Asian spinout ecosystems.

    Long term · Suggested
  • Risk

    The eight-university governance structure creates a political pressure to distribute investments across campuses, which conflicts with the power-law portfolio construction required to generate fund-level returns.

    Medium term · Assessed
  • Precedent

    Midlands Mindforge's multi-university consortium structure, if it avoids the NPIF portfolio-dilution failure mode, could be replicated in the Yorkshire, North West and South West regional clusters within two years.

    Long term · Suggested
Sources:UKRI
Mentions:University of Oxford →Emory University →University of Liverpool →UKRI →DSIT →Open Rights Group →British Business Bank →Nesta →London →Birmingham →Nottingham →Munich →Germany →Cambridge →Onward →Berlin →Midlands Mindforge →Lord Patrick Vallance →Loughborough University →Cranfield University →Local Innovation Partnerships Fund →Cambridge Innovation Capital →
First Reported In

Update #8 · London startup raises Britain's own AI model

UKRI· 14 Jun 2026
Read original →
Causes and effects
Caused by
Mayors get the £500m grant pen
Midlands Mindforge's first deployments echo the £500m LIPF devolution DSIT handed to seven city-region mayors at the start of June, both chipping at Golden Triangle concentration.
Occurred 1 Jun 2026
Read story →
Lansdowne hits €128.9m on BBB-anchored fund
Midlands Mindforge follows the Lansdowne university-IP fund the British Business Bank anchored in May, both targeting regional spinout capital.
Occurred 14 May 2026
Read story →
This Event
Midlands fund writes its first cheques
The first multi-university Midlands spinout fund to reach deployment chips at the Oxford-Cambridge-London concentration that has defined British spinout capital for a decade.
Led to
Neubond seed is Japan VC's UK first
Midlands Mindforge's £30m of university deals showed foreign-adjacent and institutional capital reaching UK spinouts; Neubond's Japanese academic VC extends that channel.
Occurred 15 Jun 2026
Read story →
Spinout deals fall 33% as seed dries up
Midlands Mindforge's university-spinout fund is one of the private vehicles rebuilding the sub-GBP2m spinout tier the tracker shows contracting.
Occurred 1 Jul 2026
Read story →
Different Perspectives
Abu Dhabi Investment Council
Abu Dhabi Investment Council
The Abu Dhabi Investment Council holds notes in Nscale's $3.36bn pre-IPO raise, beside Third Point, Apollo, Citadel and Nvidia. No British institution appears among the named holders of notes that convert into shares at Nscale's New York listing.
CDP Venture Capital
CDP Venture Capital
CDP Venture Capital, the venture arm of Italy's state lender, led TrueLayer's £20.4m round to expand Pay by Bank across Europe. A foreign state investor set the terms on a London fintech round in the same month the British Business Bank mostly followed.
EDBI
EDBI
Singapore's state investor EDBI joined Universal Quantum's Series A of more than $100m, and the Sussex company is opening its first research centre outside Europe in Singapore. British state money is absent from the largest Series A by a UK quantum company.
Forbion
Forbion
Forbion co-led OMass Therapeutics' $310m Series C with Bain Capital Life Sciences and Novo Holdings, while the British Business Bank and Syncona followed. The terms of the Oxford spinout's round were set by investors from three countries, none of them Britain.
British Business Bank
British Business Bank
The Bank committed £180m to six AI funds on 15 October with no UK-deployment condition, yet led the first close of Microbiotica's £36m Series C. That lead, with Airtel Money choosing London for its £5.3bn debut, is the evidence that British money and markets still set some terms.
Stryker Corporation
Stryker Corporation
Stryker called its roughly $400m CMR Surgical deal its entry into soft-tissue robotics, taking US sales rights for Versius, a board seat and an exclusive option over 100% of the company. The option lets Stryker choose whether and when a Cambridge robot maker becomes part of an American group.

Written with AI from Lowdown's published reporting. Not individually reviewed by an editor. Editorial standards.